Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Résultat de la recherche
1 recherche sur le mot-clé 'Cannabis/adverse effects'
Affiner la recherche Générer le flux rss de la recherche
Partager le résultat de cette recherche Faire une suggestion
Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development / Carolyn G. DIGUISEPPI in Journal of Autism and Developmental Disorders, 52-11 (November 2022)
[article]
Titre : Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development Type de document : Texte imprimé et/ou numérique Auteurs : Carolyn G. DIGUISEPPI, Auteur ; Tessa CRUME, Auteur ; Julia VAN DYKE, Auteur ; Katherine R. SABOURIN, Auteur ; Gnakub N. SOKE, Auteur ; Lisa A. CROEN, Auteur ; Julie L. DANIELS, Auteur ; Li-Ching LEE, Auteur ; Laura A. SCHIEVE, Auteur ; Gayle C. WINDHAM, Auteur ; Sandra FRIEDMAN, Auteur ; Cordelia ROBINSON ROSENBERG, Auteur Article en page(s) : p.5064-5071 Langues : Anglais (eng) Mots-clés : Autism Spectrum Disorder/epidemiology Cannabis/adverse effects Case-Control Studies Female Humans Pregnancy Autism spectrum disorder Cannabis Epidemiology Marijuana interest. Index. décimale : PER Périodiques Résumé : The association of autism spectrum disorder (ASD) with self-reported maternal cannabis use from 3Â months pre-conception to delivery ("peri-pregnancy") was assessed in children aged 30-68Â months, born 2003 to 2011. Children with ASD (N=1428) were compared to children with other developmental delays/disorders (DD, N=1198) and population controls (POP, N=1628). Peri-pregnancy cannabis use was reported for 5.2% of ASD, 3.2% of DD and 4.4% of POP children. Adjusted odds of peri-pregnancy cannabis use did not differ significantly between ASD cases and DD or POP controls. Results were similar for any use during pregnancy. However, given potential risks suggested by underlying neurobiology and animal models, further studies in more recent cohorts, in which cannabis use and perception may have changed, are needed. En ligne : http://dx.doi.org/10.1007/s10803-021-05339-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=489
in Journal of Autism and Developmental Disorders > 52-11 (November 2022) . - p.5064-5071[article] Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development [Texte imprimé et/ou numérique] / Carolyn G. DIGUISEPPI, Auteur ; Tessa CRUME, Auteur ; Julia VAN DYKE, Auteur ; Katherine R. SABOURIN, Auteur ; Gnakub N. SOKE, Auteur ; Lisa A. CROEN, Auteur ; Julie L. DANIELS, Auteur ; Li-Ching LEE, Auteur ; Laura A. SCHIEVE, Auteur ; Gayle C. WINDHAM, Auteur ; Sandra FRIEDMAN, Auteur ; Cordelia ROBINSON ROSENBERG, Auteur . - p.5064-5071.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 52-11 (November 2022) . - p.5064-5071
Mots-clés : Autism Spectrum Disorder/epidemiology Cannabis/adverse effects Case-Control Studies Female Humans Pregnancy Autism spectrum disorder Cannabis Epidemiology Marijuana interest. Index. décimale : PER Périodiques Résumé : The association of autism spectrum disorder (ASD) with self-reported maternal cannabis use from 3Â months pre-conception to delivery ("peri-pregnancy") was assessed in children aged 30-68Â months, born 2003 to 2011. Children with ASD (N=1428) were compared to children with other developmental delays/disorders (DD, N=1198) and population controls (POP, N=1628). Peri-pregnancy cannabis use was reported for 5.2% of ASD, 3.2% of DD and 4.4% of POP children. Adjusted odds of peri-pregnancy cannabis use did not differ significantly between ASD cases and DD or POP controls. Results were similar for any use during pregnancy. However, given potential risks suggested by underlying neurobiology and animal models, further studies in more recent cohorts, in which cannabis use and perception may have changed, are needed. En ligne : http://dx.doi.org/10.1007/s10803-021-05339-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=489